Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Microb Pathog ; 150: 104740, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33460748

RESUMO

Hepatitis C virus is an infectious pathogen affecting thousands of people causing great damage to the liver and consider an important cause of morbidity and mortality in developing countries. This research was conducted on 30 patients infected with hepatitis C virus and 10 control normal volunteers after taking consent of them in order to evaluate the liver function and antioxidants profile after treatment with combination of Sofosbuvir and Ribaverin in hepatitis C virus patients. The results showed significant reduction of elevated levels of L-Malondialdhyde, Alanine Aminotrasferase, Aspartate Aminotrasferase, Alkaline Phosphatase, Albumin, Total protein, Total bilirubin and α-fetoprotein mean while significant increase in glutathione peroxidase, catalase, superoxide dismutase activity upon treatment with combination of sofosbuvir plus ribavirin. In conclusion, the present finding suggest that, treatment of hepatitis C virus patient with combination of Sofosbuvir and Ribavirin significantly improve liver function parameters and antioxidant profile.


Assuntos
Antioxidantes , Hepatite C Crônica , Antioxidantes/uso terapêutico , Antivirais/uso terapêutico , Quimioterapia Combinada , Genótipo , Hepacivirus , Hepatite C Crônica/tratamento farmacológico , Humanos , Ribavirina/uso terapêutico , Sofosbuvir , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA